HAVE OUR BACKS
×
Sign Up
Already Registered?
face
lock_outline
THE FACTS
BIO
BIO
VOTES
VOTES
POSITIONS
POSITIONS
RATINGS
RATINGS
SPEECHES
SPEECHES
FUNDING
FUNDING
Please have our backs
No Thank You
Katie Porter's Public Statements on Issue: Drugs
Office:
U.S. House (CA)
- District 47, Democratic
Track This Politician
Current Issue:
Drugs
Select Issue
All
Abortion
Agriculture and Food
Animals and Wildlife
Arts, Entertainment, and History
Business and Consumers
Campaign Finance
Civil Liberties and Civil Rights
Constitution
Criminal Justice
Death Penalty
Defense
Drugs
Economy and Fiscal
Education
Elections
Employment and Affirmative Action
Energy
Entitlements and the Safety Net
Environment
Executive Branch
Family
Federal, State and Local Relations
Finance and Banking
Food Processing and Sales
Foreign Affairs
Foreign Aid
Gambling and Gaming
Government Budget and Spending
Government Operations
Guns
Health Insurance
Health and Health Care
Higher Education
Housing and Property
Immigration
Indigenous Peoples
Infrastructure
Judicial Branch
K-12 Education
Labor Unions
Legal
Legislative Branch
Marijuana
Marriage
Military Personnel
Minors and Children
Monetary Policy
National Security
Natural Resources
Oil and Gas
Religion
Reproduction
Science
Senior Citizens
Sexual Orientation and Gender Identity
Stem Cell Research
Taxes
Technology and Communication
Trade
Transportation
Unemployed and Low-Income
Veterans
Women
Speech Type
Select Speech Type
All
Debate
Executive Order
Floor Speech
Hearing
Interview
Issue Position
Letter
News Article
Op-Ed
Other
Pledge
Press Conference
Press Release
Social Media
Speech
Statement
Date Range
Start Date
End Date
Apply
Keyword Search
close
Reset Search
attach_money
Who is funding Porter?
Date
Title
04/11/2022
Letter to Various Pharmaceutical CEOs - Baldwin, Maloney, Hassan, King, Fitzpatrick, Lead Bipartisan, Bicameral Group in Calling on Drug Manufacturers to Make Naloxone Available Over the Counter
03/16/2022
Schakowsky, Warren, Klobuchar, Porter, Colleagues Call Out Drug Manufacturers For Providing Misleading Information on High Drug Prices
03/01/2022
Letter to Stephen J. Ubl, President and CEO of PhRMA - Senator Baldwin, Colleagues Call Out Drug Manufacturers For Squeezing American Families With Rapid and Widespread Price Hikes on Prescription Drugs
12/07/2021
Letter to Hon. Chuck Schumer, Majority Leader US Senate - Keep Affordable Insulin Measures in Build Back Better Act
04/14/2021
Reps. Porter, DeLauro Reintroduce Legislation to Protect Patients from Paying More for Drugs
04/06/2021
Letter to Secretary of Health and Human Services, Xavier Beccera - Trone, Kuster, Barragán, Porter Lead Letter to HHS Urging Extension and Expansion of Public Health Emergency from Opioid Crisis
09/25/2019
With Rep. Porter Support, House Passes Bipartisan Bill to Protect Financial Institutions that Service State-Legal Marijuana Businesses
08/19/2019
Letter to the Hon. William Barr, Attorney General of the U.S. Department of Justice - Representative Mike Levin Requests Information from DOJ on Enforcement of Patient Brokering Law
06/05/2019
Letter to the Hon. Robert Wilkie, Secretary of the Department of Veteran Affairs - Rep. Tulsi Gabbard: Protect VA Benefits for Veterans Employed in State-Legalized Cannabis Industry
03/29/2019
Rep. Porter-backed Bill to Protect Financial Institutions Serving Marijuana Businesses Clears Key Committee Hurdle
attach_money
Who is funding Porter?
clear
Log in
face
lock_outline
face
person
person_outline
email
lock
lock_outline
Enter the same password as above, for verification.
arrow_upward